Quince Therapeutics logo

Quince Therapeutics Share Price (NASDAQ: QNCX)

$1.58

0.04

(2.6%)

Last updated on

Check the interactive Quince Therapeutics Stock chart to analyse performance

Quince Therapeutics stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$1.49
    Today's High:$1.61

    Day's Volatility :7.17%

  • 52 Weeks Low:$0.66
    52 Weeks High:$2.45

    52 Weeks Volatility :73.14%

Quince Therapeutics Stock Returns

PeriodQuince Therapeutics IncIndex (Russel 2000)
3 Months
50.0%
0.0%
6 Months
9.66%
0.0%
1 Year
129.44%
0.0%
3 Years
-3.64%
-4.7%

Quince Therapeutics Inc Key Stats

Check Quince Therapeutics key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.54
Open
$1.52
Today's High
$1.605
Today's Low
$1.49
Market Capitalization
$83.8M
Today's Volume
$224.9K
52 Week High
$2.45
52 Week Low
$0.6581
Revenue TTM
$0.0
EBITDA
$-38.8M
Earnings Per Share (EPS)
$-1.1
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-167.04%

Stock Returns calculator for Quince Therapeutics Stock including INR - Dollar returns

The Quince Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Quince Therapeutics investment value today

Current value as on today

₹2,34,270

Returns

₹1,34,270

(+134.27%)

Returns from Quince Therapeutics Stock

₹1,28,986 (+128.99%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Quince Therapeutics Stock

-47%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Quince Therapeutics Stock from India on INDmoney has decreased by -47% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Quince Therapeutics Inc

  • Name

    Holdings %

  • Nantahala Capital Management, LLC

    4.71%

  • Vanguard Group Inc

    2.71%

  • IEQ CAPITAL, LLC

    1.50%

  • Renaissance Technologies Corp

    0.93%

  • Geode Capital Management, LLC

    0.74%

  • BlackRock Inc

    0.64%

Analyst Recommendation on Quince Therapeutics Stock

Rating
Trend

Sell

    0%Buy

    50%Hold

    50%Sell

Based on 6 Wall street analysts offering stock ratings for Quince Therapeutics(by analysts ranked 0 to 5 stars)

Quince Therapeutics Share Price Target

What analysts predicted

Upside of 374.68%

Target:

$7.50

Current:

$1.58

Quince Therapeutics share price target is $7.50, a slight Upside of 374.68% compared to current price of $1.58 as per analysts' prediction.

Quince Therapeutics Stock Insights

  • Price Movement

    In the last 3 months, QNCX stock has moved up by 52.9%
  • QNCX vs ALNY (3 yr)

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 112.6% return, outperforming this stock by 123.8%

Quince Therapeutics Technicals Summary

Sell

Neutral

Buy

Quince Therapeutics is currently in a neutral trading position according to technical analysis indicators.

Quince Therapeutics Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Quince Therapeutics Inc logo
-5.92%
9.66%
129.44%
-3.64%
-96.39%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Quince Therapeutics Inc

Quince Therapeutics, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. The company's lead asset candidature comprises EryDex for the treatment of rare pediatric neurodegenerative disease, including A-T, an inherited autosomal recessive neurodegenerative and immunodeficiency disorder caused by mutations in ATM gene. Its AIDE technology platform, a drug/device combination platform that uses an automated process to encapsulate a drug into a patient's own red blood cells, as well as consists of an automated equipment the RCL, a sterile single-use consumable treatment kit comprising kit medical devices, syringe kit, and process solutions. The company was formerly known as Cortexyme, Inc. and changed its name to Quince Therapeutics, Inc. in August 2022. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
Organization
Quince Therapeutics
Employees
36
CEO
Dr. Dirk Thye M.D.
Industry
Healthcare

Key Management of Quince Therapeutics Inc

NameTitle
Dr. Dirk Thye M.D.
CEO, Chief Medical Officer & Director
Dr. Charles S. Ryan J.D., Ph.D.
President
Mr. Brendan Hannah M.B.A.
Chief Business Officer, COO, Chief Compliance Officer and Principal Financial & Accounting Officer
Mr. Giovanni Mambrini M.Sc.
Chief Technology Officer
Dr. Guenter R. Janhofer M.D., Ph.D.
Chief Scientific Officer
Ms. Stacy Roughan
Vice President of Corporate Communications & Investor Relations
Ms. Mary Ellen Sillivos
Vice President of Human Resources
Dr. Stewart A. Low Ph.D.
Head of Discovery
Ms. Pamela M. Williamson FRAPS, M.B.A., RAC
Head of Regulatory Affairs

Important FAQs about investing in QNCX Stock from India :

What is Quince Therapeutics share price today?

Quince Therapeutics share price today is $1.58 as on at the close of the market. Quince Therapeutics share today touched a day high of $1.61 and a low of $1.49.

What is the 52 week high and 52 week low for Quince Therapeutics share?

Quince Therapeutics share touched a 52 week high of $2.45 and a 52 week low of $0.66. Quince Therapeutics stock price today i.e. is closed at $1.58, lower by 35.51% versus the 52 week high.

How to invest in Quince Therapeutics Stock (QNCX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Quince Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Quince Therapeutics Shares that will get you 0.9494 shares as per Quince Therapeutics share price of $1.58 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Quince Therapeutics Stock (QNCX) from India?

Indian investors can start investing in Quince Therapeutics (QNCX) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Quince Therapeutics stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Quince Therapeutics share’s latest price of $1.58 as on August 30, 2025 at 1:29 am IST, you will get 6.3291 shares of Quince Therapeutics. Learn more about fractional shares .

What are the returns that Quince Therapeutics has given to Indian investors in the last 5 years?

Quince Therapeutics stock has given -96.39% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?